ARWR earnings: real EPS beat/miss history, analyst consensus Buy, P/E -41.45. Updated 2026-07-23.
Arrowhead Pharmaceuticals (ARWR) Research Hub
Arrowhead Pharmaceuticals (ARWR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 82.85 USD (+0.27%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -41.45, market cap 12.70B. This hub links to the full technical, earnings and options research available for ARWR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 82.85 USD (+0.27%) |
| 52-week range | 69.88 USD – 95.49 USD |
| Trend regime | Range |
| 14-day RSI | 41.3 (Bearish) |
| Trailing P/E | -41.45 |
| Market cap | 12.70B |
| Dividend yield | 0.00% |
Available research for ARWR
Covered Call on ARWR: how it works, illustrative setup around the real 82.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ARWR: how it works, illustrative setup around the real 82.85 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ARWR: how it works, illustrative setup around the real 82.85 USD price, max profit/loss, breakeven and when to use it. Educational.
ARWR technical analysis: range, last 82.85 USD, RSI 41.3, 52w range 69.88 USD–95.49 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is ARWR in?
Arrowhead Pharmaceuticals (ARWR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ARWR in an uptrend or downtrend?
As of 2026-09-11, ARWR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ARWR's trailing P/E ratio?
ARWR's trailing P/E is -41.45, with a market cap of 12.70B. See the earnings research page for full valuation detail.